BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 18596922)

  • 1. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
    Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
    J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma.
    Sangodkar J; DiFeo A; Feld L; Bromberg R; Schwartz R; Huang F; Terzo EA; Choudhri A; Narla G
    Lung Cancer; 2009 Dec; 66(3):292-7. PubMed ID: 19328586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
    Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
    Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
    Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
    Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.
    Difeo A; Huang F; Sangodkar J; Terzo EA; Leake D; Narla G; Martignetti JA
    Cancer Res; 2009 Jun; 69(11):4733-41. PubMed ID: 19435908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
    Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
    J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
    Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
    Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response.
    DiFeo A; Feld L; Rodriguez E; Wang C; Beer DG; Martignetti JA; Narla G
    Cancer Res; 2008 Feb; 68(4):965-70. PubMed ID: 18250346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
    Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.
    Chiam K; Ryan NK; Ricciardelli C; Day TK; Buchanan G; Ochnik AM; Murti K; Selth LA; ; Butler LM; Tilley WD; Bianco-Miotto T
    Prostate; 2013 Jan; 73(2):182-93. PubMed ID: 22782870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis.
    Izadmehr S; Fernandez-Hernandez H; Wiredja D; Kirschenbaum A; Lee-Poturalski C; Tavassoli P; Yao S; Schlatzer D; Hoon D; Difeo A; Levine AC; Mosquera JM; Galsky MD; Cordon-Cardo C; Narla G
    bioRxiv; 2024 Feb; ():. PubMed ID: 38352401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
    Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
    Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.